Evaluation of the Effects of Eccentric Training on a Cycle Ergometer, Versus Conventional Concentric Training
ENERGETIC
1 other identifier
interventional
212
1 country
2
Brief Summary
The aim of this study is to assess the efficacy of a rehabilitation protocol based on individualized combined eccentric and concentric cycle ergometer training compared to classical concentric cycle training among patients with either coronary artery disease (CAD) or chronic obstructive pulmonary disease (COPD). This study will therefore evaluate the efficacy of combined eccentric/concentric training on physical capacity and overall autonomy, and will analyse the adaptive mechanisms with regard to both adaptation to cardiac and muscular effort and tolerance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2013
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 16, 2013
CompletedFirst Submitted
Initial submission to the registry
March 5, 2014
CompletedFirst Posted
Study publicly available on registry
June 5, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 3, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 3, 2019
CompletedJuly 22, 2019
July 1, 2019
5.5 years
March 5, 2014
July 19, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
For patients with CAD: Distance covered during a 6-minute walk test and triceps surae maximal isometric force
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
For COPD patients : Endurance time at 75 % of peak workload achieved on a cycle ergometer during the initial concentric cardiopulmonary exercise test (CPET)
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
Secondary Outcomes (24)
For CAD patients: Functional Independence Measure
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
For CAD patients: Timed up and go test
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
For CAD patients: Step test with gas exchange measurement
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
For CAD patients: Distance covered in the 6-minute walk test
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
For CAD patients: peak VO2 and 1st ventilation adaptation threshold
Between the initial evaluation (D0) and the final reconditioning evaluation, assessed up to 8 weeks
- +19 more secondary outcomes
Study Arms (2)
"Conventional" group
EXPERIMENTAL"Combined" group
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Persons who have provided written informed consent
- Healthy volunteers:
- Men or women aged between 40 and 75 years.
- Patients with CAD:
- Men or women aged between 40 and 75 years, with coronary artery disease without heart failure referred for a rehabilitation program.
- Left ventricular ejection fraction on echocardiography (Simpson methode) \> 45 %
- Patients with Chronic obstructive pulmonary disease:
- Men or women aged between 40 and 75 years
- Severe Chronic obstructive pulmonary disease (post-bronchodilatator FEV1/FVC \< 0.70 and FEV1 ≤ 60% of predicted value)
- Patient not on oxygen therapy (24h/24)
You may not qualify if:
- Person without national health insurance cover
- Severe, obstructive cardiopathy
- Severe aortic valve stenosis,
- Severe progressive heart rhythm or conduction disorders not corrected by a pacemaker and detected during the initial effort test
- Cardiac intracavitary thrombus,
- Severe pulmonary artery hypertension (PAHT systolic \>70mmHg),
- Recent history of venous thromboembolism (previous 3 months),
- Impaired executive functions making it impossible to understand and adhere to a rehabilitation program (Mini Mental Test \< 24),
- Heart transplant,
- Associated medical condition that could substantially affect functional capacities (examples: non-stabilized metabolic disorders such as progressive renal insufficiency, major asthenia linked to a severe non-stabilized disorder such as neoplasia, systemic disease…).
- Physical incapacity of the lower limbs that could impair rehabilitation, whether they are neurological (central or peripheral), arterial (in particular, peripheral artery disease with a systolic index \< 0.6) or orthopedic (degenerative or inflammatory rheumatism).
- Patients who have taken part (within the previous 6 months) or a currently taking part in a rehabilitation program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHU de BESANCON
Besançon, 25000, France
CHU de DIJON
Dijon, 21079, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 5, 2014
First Posted
June 5, 2014
Study Start
September 16, 2013
Primary Completion
April 3, 2019
Study Completion
April 3, 2019
Last Updated
July 22, 2019
Record last verified: 2019-07